Genentech Announces Full FDA Approval for Venclexta Combinations for Acute Myeloid Leukemia
South San Francisco, CA — October 16, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX:
Read moreSouth San Francisco, CA — October 16, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX:
Read moreMyelodysplastic syndrome (MDS) is a bone marrow failure disorder characterized by intractable cytopenia and dysplastic hematological changes. MDS has a
Read moreTHURSDAY, Sept. 24, 2020 — Use of a stroke alarm clock demanding active feedback significantly improves management metrics for acute
Read moreMobile devices proved both reliable and accurate for the clinical decision to administer IV thrombolysis in patients with acute stroke,
Read moreIn a new study published in Nature Communications, researchers at Karolinska Institutet show that mucosa-associated invariant T cells (MAIT cells)
Read more